Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Fiboflapon (GSK2190915) is an orally available and effective 5-lipoxygenase-activating protein (FLAP) inhibitor that binds FLAP with a titer of 2.9 nM and inhibition of LTB4 in human blood with an IC50 of 76 nM.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 12,000 | |||
2 mg | 在庫あり | ¥ 17,000 | |||
5 mg | 在庫あり | ¥ 28,500 | |||
10 mg | 在庫あり | ¥ 45,500 | |||
25 mg | 在庫あり | ¥ 101,000 | |||
50 mg | 在庫あり | ¥ 189,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 40,000 |
ターゲット&IC50 | LTB4:76 nM |
別名 | GSK2190915, AM-803 |
分子量 | 637.83 |
分子式 | C38H43N3O4S |
CAS No. | 936350-00-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 40 mg/mL (62.71 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Fiboflapon 936350-00-4 Immunology/Inflammation FLAP AM 803 GSK2190915 AM-803 GSK-2190915 GSK 2190915 AM803 Inhibitor inhibitor inhibit